Harmless virus may hold key to safer kidney transplants
NCT ID NCT06829719
First seen Jun 04, 2026 · Last updated Jun 04, 2026
Summary
This study tests whether monitoring levels of a harmless virus called TTV can help doctors personalize immune-suppressing drugs for kidney transplant patients. The goal is to prevent long-term complications like infections, cancer, and organ rejection. About 600 adults who received a kidney transplant 1-4 years ago will take part. Their treatment will be adjusted based on TTV levels, aiming to find the right balance between preventing rejection and avoiding side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Département de Néphrologie et Transplantation d'Organes Hôpital Rangueil - CHU de Toulouse
RECRUITINGToulouse (France), 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de Néphrologie, Dialyse et Transplantation Rénale Nouvel Hôpital Civil
NOT_YET_RECRUITINGStrasbourg (france), 67091, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de Néphrologie-Transplantation-Dialyse I Hôpital Pellegrin I - CHU Bordeaux
NOT_YET_RECRUITINGBordeaux (France), 33000, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Service de transplantation, néphrologie et immunologie clinique Hospices Civils de Lyon, Hôpital Edouard Herriot
RECRUITINGLyon, 69003, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.